These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26530380)

  • 1. Trends in rates of acetaminophen-related adverse events in the United States.
    Major JM; Zhou EH; Wong HL; Trinidad JP; Pham TM; Mehta H; Ding Y; Staffa JA; Iyasu S; Wang C; Willy ME
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):590-8. PubMed ID: 26530380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States.
    Manthripragada AD; Zhou EH; Budnitz DS; Lovegrove MC; Willy ME
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):819-26. PubMed ID: 21294217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in emergency department visits attributable to acetaminophen overdoses in the United States: 1993-2007.
    Li C; Martin BC
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):810-8. PubMed ID: 21796717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hepatic injury associated with unintentional overdose of paracetamol (Acetaminophen) in products with and without opioid: an analysis using the National Poison Data System of the American Association of Poison Control Centers, 2000-7.
    Bond GR; Ho M; Woodward RW
    Drug Saf; 2012 Feb; 35(2):149-57. PubMed ID: 22149359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products.
    Goldberger D; Vearrier D
    J Med Toxicol; 2017 Dec; 13(4):303-308. PubMed ID: 28710607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency department visits for acetaminophen overdose: a Canadian population-based epidemiologic study (1997-2002).
    Myers RP; Li B; Shaheen AA
    CJEM; 2007 Jul; 9(4):267-74. PubMed ID: 17626691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poison center exposures due to therapeutic misuse of nonprescription acetaminophen-containing combination products in the United States 2007-2016.
    Brass EP; Burnham RI; Reynolds KM
    Clin Toxicol (Phila); 2019 May; 57(5):350-355. PubMed ID: 30306812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision tree outcome prediction of acute acetaminophen exposure in the United States: A study of 30,000 cases from the National Poison Data System.
    Mehrpour O; Saeedi F; Hoyte C
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130(1):191-199. PubMed ID: 34649297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetaminophen availability increases in Canada with no increase in the incidence of reports of inpatient hospitalizations with acetaminophen overdose and acute liver toxicity.
    Prior MJ; Cooper K; Cummins P; Bowen D
    Am J Ther; 2004; 11(6):443-52. PubMed ID: 15543083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department visits for overdoses of acetaminophen-containing products.
    Budnitz DS; Lovegrove MC; Crosby AE
    Am J Prev Med; 2011 Jun; 40(6):585-92. PubMed ID: 21565648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relating calls to US poison centers for potential exposures to medications to Centers for Disease Control and Prevention reporting of influenza-like illness.
    Beauchamp GA; McKeown NJ; Rodriguez S; Spyker DA
    Clin Toxicol (Phila); 2016 Mar; 54(3):235-40. PubMed ID: 26818907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based incidence and outcome of acetaminophen poisoning by type of ingestion.
    Bond GR; Hite LK
    Acad Emerg Med; 1999 Nov; 6(11):1115-20. PubMed ID: 10569383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram line crossing after acetaminophen combination product overdose.
    Kirschner RI; Rozier CM; Smith LM; Jacobitz KL
    Clin Toxicol (Phila); 2016; 54(1):40-6. PubMed ID: 26567585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of poison control centers on rural hospitalization rates for poisoning.
    Zaloshnja E; Miller T; Jones P; Litovitz T; Coben J; Steiner C; Sheppard M
    Pediatrics; 2006 Nov; 118(5):2094-100. PubMed ID: 17079583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital burden of unintentional carbon monoxide poisoning in the United States, 2007.
    Iqbal S; Law HZ; Clower JH; Yip FY; Elixhauser A
    Am J Emerg Med; 2012 Jun; 30(5):657-64. PubMed ID: 21570230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity in an infant following supratherapeutic dosing of acetaminophen for twenty-four hours.
    Kubic A; Burda AM; Bockewitz E; Wahl M
    Semin Diagn Pathol; 2009 Feb; 26(1):7-9. PubMed ID: 19292023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department visits attributed to selected analgesics, United States, 2004-2005.
    Willy M; Kelly JP; Nourjah P; Kaufman DW; Budnitz DS; Staffa J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):188-95. PubMed ID: 19116955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity.
    Rivera-Penera T; Gugig R; Davis J; McDiarmid S; Vargas J; Rosenthal P; Berquist W; Heyman MB; Ament ME
    J Pediatr; 1997 Feb; 130(2):300-4. PubMed ID: 9042136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in emergency department visits for acetaminophen-related poisonings: 2011-2019.
    Kaur J; McFaull SR; Bang F
    Health Promot Chronic Dis Prev Can; 2020 Apr; 40(4):130-133. PubMed ID: 32270671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand?
    Tong HY; Medrano N; Borobia AM; Ruiz JA; Martínez AM; Martín J; Quintana M; García S; Carcas AJ; Ramírez E
    World J Pediatr; 2017 Feb; 13(1):76-83. PubMed ID: 27457792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.